Use of Hearts Transplanted From Donors With Severe Sepsis and Infectious Deaths

Journal of Heart and Lung Transplantation

Volumn 28, Issue 3, 2009, Pages 260-265

  Kubak, Bernard M ^a   Gregson, Aric L ^a   Pegues, David A ^a   Leibowitz, Matthew R ^a   Carlson, Magrit ^a   Marelli, Daniel ^a   Patel, Jignesh ^a   Laks, Hillel ^a   Kobashigawa, Jon A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; FLUCONAZOLE; IMIPENEM; LEVOFLOXACIN; OSELTAMIVIR; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CARDIOMYOPATHY; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; GRAM POSITIVE COCCI; HEART EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; INFLUENZA; MALE; NEISSERIA MENINGITIDIS; ORGAN DONOR; PNEUMOCOCCAL MENINGITIS; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEPTIC SHOCK; SINGLE DRUG DOSE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MILLERI; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; BACTERIAL INFECTIONS; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEPSIS; SEVERITY OF ILLNESS INDEX; TISSUE DONORS; YOUNG ADULT;

EID: 61749102272     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.11.911     Document Type: Article

References (24)

1. 1999 Annual report of the U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: transplant data 1989-1998 (1999), United Network for Organ Sharing, Richmond, VA
2. 2005 Annual report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry for Transplant Recipients: transplant data 1994-2004 (2005), United Network for Organ Sharing, Richmond, VA
3. Burton C.M., Milman N., Carlsen J., et al. Survival after single lung, double lung, and heart-lung transplantation. J Heart Lung Transplant 24 (2005) 1834-1843
4. Marelli D., Tsai F., Laks H., et al. Use of hearts transplanted from donors with atraumatic intracranial bleeds. J Heart Lung Transplant 20 (2001) 256
5. Milano A., Livi U., Casula R., et al. Influence of marginal donors on early results after heart transplantation. Transplant Proc 25 (1993) 3158-3159
6. Bull D.A., Stahl R.D., McMahan D.L., et al. The high risk heart donor: potential pitfalls. J Heart Lung Transplant 14 (1995) 424-428
7. Freeman R.B., Giatras I., Falagas M.E., et al. Outcome of transplantation of organs procured from bacteremic donors. Transplantation 68 (1999) 1107-1111
8. Gottesdiener K.M. Transplanted infections: donor-to-host transmission with the allograft. Ann Intern Med 110 (1989) 1001-1016
9. Nery J.R., Weppler D., Ketchum P., et al. Donor infection and primary nonfunction in liver transplantation. Transplant Proc 29 (1997) 481-483
10. Keating M.R., Guerrero M.A., Daly R.C., et al. Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients. Chest 109 (1996) 1119-1124
11. Cerutti E., Stratta C., Romagnoli R., et al. Bacterial- and fungal-positive cultures in organ donors: clinical impact in liver transplantation. Liver Transplant 12 (2006) 1253-1259
12. Sozen H., Fidan K., Mahli A., et al. Successful solid organ transplantation from septicemic cadaveric donors: case report. Transplant Proc 40 (2008) 299-301
13. Zibari G.B., Lipka J., Zizzi H., et al. The use of contaminated donor organs in transplantation. Clin Transplant 14 (2000) 397-400
14. Lumbreras C., Sanz F., Gonzalez A., et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis 33 (2001) 722-726
15. Battaglia M., Ditonno P., Selvaggio O., et al. Kidney transplants from infected donors: our experience. Transplant Proc 36 (2004) 491-492
16. Gonzalez-Segura C., Pascual M., Garcia Huete L., et al. Donors with positive blood culture: could they transmit infections to the recipients?. Transplant Proc 37 (2005) 3664-3666
17. Cohen J., Michowiz R., Ashkenazi T., et al. Successful organ transplantation from donors with Acinetobacter baumannii septic shock. Transplantation 81 (2006) 853-855
18. Paredes D., Gambra M.P., Cervera C., et al. Characterization of the organ donor with bacteremia. Transplant Proc 39 (2007) 2083-2085
19. Lammermeier D.E., Sweeney M.S., Haupt H.E., et al. Use of potentially infected donor hearts for cardiac transplantation. Ann Thorac Surg 50 (1990) 222-225
20. Jeevanandam V., Furukawa S., Prendergast T.W., et al. Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg 62 (1996) 1268-1275
21. Kumar D., Cattral M.S., Robicsek A., et al. Outbreak of Pseudomonas aeruginosa by multiple organ transplantation from a common donor. Transplantation 75 (2003) 1053-1055
22. Kono T., Nishina T., Morita H., et al. Usefulness of low-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction. Am J Cardiol 84 (1999) 578-582
23. Zaroff J.G., Rosengard B.R., Armstrong W.F., et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation 106 (2002) 836-841
24. Faust S.N., Levin M., Harrison O.B., et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 345 (2001) 408-416